Relationship between gastric mucosal atrophy by endoscopy and non-ampullary duodenal epithelial tumors

doi:10.4251/wjgo.v17.i2.100545

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (200)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

HTML

Figures (1-3)

Tables (1-4)

Sum=172

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=10

Feb 15, 2025 (publication date) through Feb 1, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Feb 15, 2025; 17(2): 100545
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100545

Table 2 Patient characteristics, n (%)

Variable	Category or unit	Gastric atrophy		P value
Variable	Category or unit	Type C, n = 105	Type O, n = 29	P value
Age	Year	65.15 (11.29)	71.93 (6.60)	0.002
Sex	Female	36 (34.3)	4 (13.8)	0.039
Sex	Male	69 (65.7)	25 (86.2)
Position	Part 1	17 (16.2)	7 (24.1)	0.014
	Part 2	44 (41.9)	18 (62.1)
	Part 3	44 (41.9)	4 (13.8)
Form	0-I	17 (16.2)	10 (34.5)	0.018
	0-IIa	55 (52.4)	17 (58.6)
	0-IIc	31 (29.5)	2 (6.9)
	Advanced	2 (1.9)	0 (0.0)
Therapy	ER	99	27	0.810
Therapy	Surgery	6	2
Tumor maximum length, mm		11.9 (9.5)	9.8 (7.6)	0.281
Vienna classification	Category 3	40 (38.1)	14 (48.3)	0.393
Vienna classification	Category 4 or 5	65 (61.9)	15 (51.7)
Depth	M	100 (95.2)	29 (100.0)	1.000
	SM	3 (2.9)	0 (0.0)
	≥ MP	2 (1.9)	0 (0.0)
Mucin phenotype	Gastric type	16 (15.2)	0 (0.0)	0.032
	GI type	30 (28.6)	7 (24.1)
	Intestinal type	59 (6.2)	22 (75.9)
Helicobacter pylori	Previous	32 (30.5)	8 (27.6)	< 0.001
	Current	8 (7.6)	21 (72.4)
	Uninfected	65 (61.9)	0 (0.0)
PPI	Dose (yes)	26 (24.8)	6 (20.7)	0.807
PPI	Dose (no)	79 (75.2)	23 (79.3)

Type C: No or mild endoscopic gastric mucosal atrophy; Type O: Severe endoscopic gastric mucosal atrophy; ER: Endoscopic resection; GI: Gastrointestinal; M: Mucosa; MP: Muscularis propria; PPI: Proton pump inhibitor; SM: Submucosa.

Citation: Ohno K, Nakatani E, Kurokami T, Kawai A, Itai R, Matsuda M, Masui Y, Satoh T, Ikeda S, Hirata T, Takeda S, Suzuki M, Haruma K. Relationship between gastric mucosal atrophy by endoscopy and non-ampullary duodenal epithelial tumors. World J Gastrointest Oncol 2025; 17(2): 100545
URL: https://www.wjgnet.com/1948-5204/full/v17/i2/100545.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.100545